médico cirujano tituladocédula profesionalinglés avanzadoatención a pacientesdeseable: oncología
Descripción
Company Description Immunocine Cancer Center is dedicated to advancing revolutionary immunotherapy for cancer patients, particularly those ineligible for FDA clinical trials. At the core of our innovation is Immunocine Dendritic Cell Therapy (IDCT), a proprietary treatment that “double loads” a patient’s dendritic cells with their cancer cells to trigger a strong, targeted immune response. Backed by over 16 years of research and ongoing FDA trials, IDCT represents a less invasive and precise ap…